RUNX1-RUNX1T1 (AML1-ETO) t(8;21) Detection, Quantitative
2010138
Ordering Recommendation
Detect and quantitate RUNX1-RUNX1T1 fusions arising from t(8;21) in acute myeloid leukemia (AML).
Mnemonic
AML1-ETO Q
Methodology
Quantitative Reverse Transcription Polymerase Chain Reaction
Performed
RNA isolation: Sun-Sat
Assay: Varies
Reported
5-7 days  
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
Specimen Required
Patient Preparation
  
Collect
Lavender (EDTA) or bone marrow (EDTA).  
Specimen Preparation
Transport 5 mL whole blood. (Min: 1 mL) OR Transport 3 mL bone marrow. (Min: 1 mL) Specimens must be received within 48 hours of collection due to lability of RNA.  
Storage/Transport Temperature
Refrigerated.  
Unacceptable Conditions
Serum or plasma. Specimens collected in anticoagulants other than EDTA. Severely hemolyzed, or clotted specimens.  
Remarks
  
Stability
Ambient: 1 hour; Refrigerated: 48 hours; Frozen: Unacceptable  
Reference Interval
   
Interpretive Data
Refer to report.

See Compliance Statement B: www.aruplab.com/CS  
Note
 
CPT Code(s)
81401
Components
Component Test Code*Component Chart Name
2010139RUNX1-RUNX1T1 Result
2010140RUNX1-RUNX1T1/ABL1 Ratio
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • t(8;21) (RUNX1-RUNX1T1 (AML1-ETO) t(8;21) Detection, Quantitative)